A potential nanobiotechnology platform based on infectious bursal disease subviral particles.
A potential nanobiotechnology platform based on infectious bursal disease subviral particles.
复制标题
基于传染性法氏囊病亚病毒颗粒的潜在纳米生物技术平台。
DOI:
10.1039/c2ra00857b
复制
发表时间:
2012
期刊:
影响因子:
3.9
通讯作者:
Schillberg,Stefan
中科院分区:
文献类型:
--
作者:
Taghavian,Omid;Mandal,ManojK;Steinmetz,NicoleF;Rasche,Stefan;Spiegel,Holger;Fischer,Rainer;Schillberg,Stefan
We describe a novel nanobiotechnology platform based on subviral particles derived from Infectious bursal disease virus (IBD-SVPs). The major virus coat protein VP2 assembles into spherical, 23 nm SVPs when expressed as a heterologous protein in the yeast Pichia pastoris. We recovered up to 38 mg of IBD-SVPs at > 95% purity from 1 L of recombinant yeast culture. The purified particles were able to tolerate organic solvents up to 20% concentration (ethanol or dimethylsulfoxide), they resisted temperatures up to 65 °C and remained stable over a wide pH range (2.5–9.0). We achieved bioconjugation to the amine groups of lysine residues and to the carboxyl groups of aspartic and glutamic acid residues, allowing the functionalization of IBD-SVPs with biotin. The accessibility of surface amine groups was measured using Alexa Fluor 488 N-hydroxysuccinimide (NHS) ester, an amine-selective fluorescent dye, revealing that approximately 60 dye molecules were attached to the surface of each particle. IBD-SVPs can therefore be exploited as a robust and versatile nanoscaffold to display diverse functional ligands.